Evidence mapPaperPMID 37628624Full record

SynthesisGenes2023

Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review.

Ruolin Li, Fereshteh Shokri, Alejandro Lopez Rincon, Fernando Rivadeneira, Carolina Medina-Gomez, Fariba Ahmadizar

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ruolin LiDepartment of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-2002-5806
Fereshteh ShokriDepartment of Epidemiology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0003-3910-5697
Alejandro Lopez RinconDepartment of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
Fernando RivadeneiraDepartment of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Carolina Medina-GomezDepartment of Internal Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Fariba AhmadizarDepartment of Epidemiology, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-6261-9445
Erasmus MC · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeBacteroidesBifidobacteriumGlucoseHumansGlucoseglucose-lowering medicationsgut microbiometype 2 diabetes mellitus

Identifiers

PMID37628624
PMCPMC10454120
OpenAlexW4385455062

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.